ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

For Research Projects In Cancer Therapy

March 1, 1996

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

July 21, 2000

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

NIH Review Process A Disaster, Borek Says

October 19, 1979

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts

February 14, 1986